Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Switch to ocrelizumab in MS patients treated with natalizumab in extended interval dosing at high risk of PML: A 96-week follow-up pilot study.
Santiago-Setien P, Barquín-Rego C, Hernández-Martínez P, Ezquerra-Marigomez M, Torres-Barquin M, Menéndez-Garcia C, Uriarte F, Jiménez-López Y, Misiego M, Sánchez de la Torre JR, Setien S, Delgado-Alvarado M, Riancho J. Santiago-Setien P, et al. Among authors: setien s. Front Immunol. 2023 Feb 1;14:1086028. doi: 10.3389/fimmu.2023.1086028. eCollection 2023. Front Immunol. 2023. PMID: 36817456 Free PMC article.
Effectiveness of two procedures for deploying a facilitated collaborative modeling implementation strategy-the PVS-PREDIAPS strategy-to optimize type 2 diabetes prevention in primary care: the PREDIAPS cluster randomized hybrid type II implementation trial.
Sanchez A, Pablo S, Garcia-Alvarez A, Dominguez S, Grandes G; PREDIAPS Group. Sanchez A, et al. Implement Sci. 2021 May 27;16(1):58. doi: 10.1186/s13012-021-01127-x. Implement Sci. 2021. PMID: 34044869 Free PMC article. Clinical Trial.
Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study.
Riancho J, Setien S, Sánchez de la Torre JR, Torres-Barquin M, Misiego M, Pérez JL, Castillo-Triviño T, Menéndez-García C, Delgado-Alvarado M. Riancho J, et al. Among authors: setien s. Front Immunol. 2021 Mar 25;12:614715. doi: 10.3389/fimmu.2021.614715. eCollection 2021. Front Immunol. 2021. PMID: 33841397 Free PMC article.
Fidelity evaluation of the compared procedures for conducting the PVS-PREDIAPS implementation strategy to optimize diabetes prevention in primary care.
Sánchez A, Rogers HL, Pablo S, García E, Rodríguez I, Flores MA, Galarza O, Gaztañaga AB, Martínez PA, Alberdi E, Resines E, Llarena AI, Grandes G; PREDIAPS Group. Sánchez A, et al. BMC Fam Pract. 2021 Feb 11;22(1):34. doi: 10.1186/s12875-021-01378-z. BMC Fam Pract. 2021. PMID: 33573600 Free PMC article.
Stroke with polyvascular atherothrombotic disease.
Blanco M, Sobrino T, Montaner J, Medrano V, Jiménez C, Masjuán J, Gómez-Escalonilla C, de Luis P, Arboix A, Castillo J; MITICO Study. Blanco M, et al. Atherosclerosis. 2010 Feb;208(2):587-92. doi: 10.1016/j.atherosclerosis.2009.07.041. Epub 2009 Jul 28. Atherosclerosis. 2010. PMID: 19695570